Gilead Sues Over Counterfeit HIV Drugs + Menarini’s New Rapid COVID-19 PCR Test

In this episode, Ayesha discussed Gilead Science’s lawsuit against a network of distributors selling counterfeits of the company’s best-selling HIV drugs Biktarvy and Descovy. The drugs were being sold in pharmacies across several states. Gilead said it had been working with the US Marshals and local law enforcement to conduct seizures of over 85,000 bottles of the counterfeit drugs. Gilead says it’s taking action to ensure the counterfeits are removed from circulation. The editorial team talked about the significant dangers of counterfeit drugs with respect to patient safety and that stricter regulations around tracking and audits at pharmacies should be implemented to prevent the distribution of counterfeit products. The editorial team also discussed Menarini Diagnostics’ new PCR-based COVID-19 test that can detect all of the variants of SARS-CoV-2, including Omicron.  Read the full articles here:  Gilead Sues Distributors Selling Counterfeit HIV Drugs Menarini Diagnostics’ New COVID-19 Test Detects Variants Including Omicron For more life science and medical device content, visit the Xtalks Vitals homepage. Follow Us on Social Media Twitter: @Xtalks Instagram: @Xtalks Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured